MYGN Stock Might Gain From SneakPeek Availability in Retail Stores

Myriad Genetics, Inc. (MYGN) recently made SneakPeek available over the counter in more than 8,800 retail locations nationwide. SneakPeek is the first at-home early fetal sex test for use at six weeks, now available on shelves in Walmart, Walgreens and CVS stores. Through the SneakPeek test, Myriad Genetics is on a mission to make DNA-based prenatal information affordable and accessible for all families.MYGN Stock Movement Following the NewsFollowing the news, shares of MYGN fell 2.4% to $15.78 at yesterday ...